This year, like most others in recent memory, medical plan costs are up by as much as 7%. A International Foundation of Employee Benefit Plans survey found that they are paced by: utilization related ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

The collaboration will enable customers to handle sensitive patient and clinical data within secure environments.

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year ...

REDCap Cloud harmonizes real-world evidence and trial data to overcome the industry’s biggest data management challenges; lays the foundation for AI-driven research nPhase, Inc., an innovator of cloud ...

Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results from a ...

The global market for clinical data analytics is expected to grow at a compound annual growth rate of 12.5 percent by 2023, according to a Market Research Future report. Clinical data analytics ...

Healthcare revenue cycle management company Alpha II has acquired clinical data analytics company Health eFilings. Alpha II CEO Todd Dooze will lead the combined Health eFilings and Alpha II entity, ...

PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial is fully enrolledAdditional analysis of data from a Phase 1b clinical trial that included all patients treated with gedatolisib combined ...